Profile data is unavailable for this security.
About the company
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.
- Revenue in USD (TTM)0.00
- Net income in USD-14.33m
- Incorporated2000
- Employees25.00
- LocationImunon Inc997 Lenox Dr Ste 100LAWRENCEVILLE 08648United StatesUSA
- Phone+1 (609) 896-9100
- Fax+1 (609) 896-2200
- Websitehttps://imunon.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bolt Biotherapeutics Inc | 5.20m | -42.68m | 8.70m | 52.00 | -- | 0.2709 | -- | 1.67 | -22.27 | -22.27 | 2.71 | 16.72 | 0.0596 | -- | -- | 99,903.84 | -48.95 | -46.54 | -58.33 | -52.20 | -- | -- | -821.58 | -1,666.52 | -- | -- | 0.00 | -- | -2.36 | 104.50 | 8.79 | -- | -39.55 | -- |
| StimCell Enegetics Inc | 0.00 | -935.22k | 8.98m | 0.00 | -- | -- | -- | -- | -0.0461 | -0.0461 | 0.00 | -0.0738 | 0.00 | -- | -- | -- | -2,062.23 | -844.03 | -- | -- | -- | -- | -- | -18,037.46 | -- | -17.22 | -- | -- | -- | -- | -297.42 | -- | -- | -- |
| Transcode Therapeutics Inc | 0.00 | -27.16m | 9.05m | 7.00 | -- | 5.77 | -- | -- | -354.09 | -354.09 | 0.00 | 1.71 | 0.00 | -- | -- | 0.00 | -592.26 | -153.21 | -1,387.56 | -219.22 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 9.49 | -- | -- | -- |
| Lunai Bioworks Inc | 0.00 | -125.52m | 9.24m | 29.00 | -- | -- | -- | -- | -7.14 | -7.14 | 0.00 | -0.5602 | 0.00 | -- | -- | 0.00 | -212.74 | -75.79 | -361.75 | -85.18 | -- | -- | -- | -- | -- | -23.72 | -- | -- | -- | -- | -101.31 | -- | -- | -- |
| Cardio Diagnostics Holdings Inc | 15.79k | -6.55m | 9.50m | 13.00 | -- | 1.13 | -- | 601.36 | -4.07 | -4.07 | 0.0097 | 4.61 | 0.0024 | -- | 1.25 | 1,214.62 | -98.75 | -- | -104.31 | -- | -- | -- | -41,495.31 | -- | -- | -440.22 | 0.00 | -- | 104.39 | -- | -0.079 | -- | -- | -- |
| Liminatus Pharma Inc | 0.00 | -2.27m | 9.54m | -- | -- | -- | -- | -- | -0.0872 | -0.0872 | 0.00 | -0.0608 | 0.00 | -- | -- | -- | -77.46 | -- | -- | -- | -- | -- | -- | -- | -- | -12.30 | -- | -- | -- | -- | 28.85 | -- | -- | -- |
| LianBio - ADR | 0.00 | -87.98m | 9.83m | 163.00 | -- | 0.0482 | -- | -- | -0.8195 | -0.8195 | 0.00 | 1.89 | 0.00 | -- | -- | 0.00 | -28.62 | -- | -35.22 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 43.82 | -- | -- | -- |
| Imunon Inc | 0.00 | -14.33m | 10.10m | 25.00 | -- | 2.68 | -- | -- | -10.20 | -10.20 | 0.00 | 1.23 | 0.00 | -- | -- | 0.00 | -122.58 | -57.72 | -208.59 | -70.83 | -- | -- | -- | -7,752.42 | -- | -- | 0.00 | -- | -- | -- | 4.58 | -- | -38.98 | -- |
| BioVie Inc | 0.00 | -17.48m | 10.11m | 13.00 | -- | 0.5245 | -- | -- | -5.13 | -5.13 | 0.00 | 2.55 | 0.00 | -- | -- | 0.00 | -72.35 | -260.69 | -79.73 | -454.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 45.73 | -- | -- | -- |
| Inotiv Inc | 514.03m | -69.37m | 10.52m | 1.95k | -- | 0.0965 | -- | 0.0205 | -2.02 | -2.02 | 15.00 | 3.17 | 0.6821 | 10.37 | 7.71 | 264,281.20 | -9.21 | -18.23 | -16.14 | -23.64 | 23.49 | 26.43 | -13.50 | -27.50 | 0.2218 | -0.6298 | 0.7918 | -- | 4.54 | 53.36 | 36.72 | -- | 21.79 | -- |
| OSR Holdings Inc | 2.52m | -15.21m | 10.56m | -- | -- | 0.1184 | -- | 4.18 | -1.73 | -1.73 | 0.1939 | 3.46 | 0.0255 | -- | -- | -- | -22.03 | -- | -34.38 | -- | 18.35 | -- | -864.91 | -- | 0.2009 | -- | 0.0313 | -- | -- | -- | -697.08 | -- | -- | -- |
| Phio Pharmaceuticals Corp | 0.00 | -7.95m | 10.98m | 5.00 | -- | 0.5997 | -- | -- | -2.73 | -2.73 | 0.00 | 1.70 | 0.00 | -- | -- | 0.00 | -91.57 | -73.65 | -107.58 | -86.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 33.96 | -- | -57.49 | -- |
| Ainos Inc | 113.04k | -14.96m | 11.03m | 44.00 | -- | 0.754 | -- | 97.60 | -4.29 | -4.29 | 0.0307 | 2.10 | 0.0042 | 0.12 | 3,768.00 | 2,569.09 | -55.34 | -38.46 | -60.63 | -55.22 | 82.62 | 35.93 | -13,231.35 | -1,122.70 | 2.67 | -19.92 | 0.5227 | -- | -83.02 | 12.06 | -7.93 | -- | 10.22 | -- |
| Longeveron Inc | 1.44m | -21.34m | 11.63m | 25.00 | -- | 1.15 | -- | 8.09 | -1.34 | -1.34 | 0.0909 | 0.4732 | 0.0632 | -- | 6.65 | 57,480.00 | -93.88 | -70.26 | -114.04 | -83.92 | 74.88 | 44.57 | -1,485.11 | -683.81 | -- | -- | 0.00 | -- | 237.38 | -15.76 | -10.86 | -- | 51.32 | -- |
| Soligenix Inc | 0.00 | -11.46m | 11.80m | 14.00 | -- | 1.52 | -- | -- | -3.66 | -3.66 | 0.00 | 0.7705 | 0.00 | -- | -- | 0.00 | -105.25 | -73.79 | -165.82 | -151.46 | -- | 22.19 | -- | -1,147.93 | -- | -- | 0.00 | -- | -85.78 | -51.89 | -34.62 | -- | -- | -- |
Data as of Mar 03 2026. Currency figures normalised to Imunon Inc's reporting currency: US Dollar USD
17.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Dec 2025 | 266.89k | 10.59% |
| DRW Securities LLCas of 31 Dec 2025 | 58.83k | 2.33% |
| Riverview Capital Advisers LLCas of 31 Dec 2025 | 34.36k | 1.36% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 23.78k | 0.94% |
| Geode Capital Management LLCas of 31 Dec 2025 | 21.22k | 0.84% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 13.27k | 0.53% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 4.46k | 0.18% |
| Wells Fargo Clearing Services LLCas of 31 Dec 2025 | 3.44k | 0.14% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 2.96k | 0.12% |
| UBS Switzerland AG (Investment Management)as of 31 Dec 2025 | 1.39k | 0.06% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
